Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic HNSCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
J. Clin. Oncol 2022 Mar 25;[EPub Ahead of Print], B Burtness, D Rischin, R Greil, D Soulières, M Tahara, G de Castro, A Psyrri, I Brana, N Basté, P Neupane, Å Bratland, T Fuereder, BGM Hughes, R Mesia, N Ngamphaiboon, T Rordorf, WZ Wan Ishak, J Ge, RF Swaby, B Gumuscu, K HarringtonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.